Evoxx Technologies
About Evoxx Technologies
Evoxx Technologies is a company founded in 2006 was acquired by Advanced Enzyme Technologies in July 2017.. The company has 15 employees as of December 31, 2022. Evoxx Technologies offers products and services including Food Processing Enzymes, Biocatalysis Enzymes, and Human Nutrition Enzymes. Evoxx Technologies operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Employees 15 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evoxx Technologies Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$553.8 K (USD), Grant
Apr 01, 2015
-
Investors
Advanced Enzyme Technologies
& 2 more
-
Employee Count
15
as on Dec 31, 2022
-
Acquired by
Advanced Enzyme Technologies
(Jul 27, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evoxx Technologies
Evoxx Technologies offers a comprehensive portfolio of products and services, including Food Processing Enzymes, Biocatalysis Enzymes, and Human Nutrition Enzymes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enzymes used for processing food products efficiently
Enzymes for chemical and pharma production processes
Enzymes as active ingredients in pharmaceutical formulations
Funding Insights of Evoxx Technologies
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $553,799
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Grant - Evoxx Technologies | Valuation |
investors |
|
| Jan, 2015 | Amount | Grant - Evoxx Technologies | Valuation |
investors |
|
| Aug, 2007 | Amount | Seed - Evoxx Technologies | Valuation | HTGF |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evoxx Technologies
Evoxx Technologies has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Advanced Enzyme Technologies, European Union and High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Enzymes are manufactured for nutrition, food, feed, and textile industries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evoxx Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Evoxx Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evoxx Technologies Comparisons
Competitors of Evoxx Technologies
Evoxx Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Evoxx Technologies
When was Evoxx Technologies founded?
Evoxx Technologies was founded in 2006 and raised its 1st funding round 1 year after it was founded.
How many employees does Evoxx Technologies have?
As of Dec 31, 2022, the latest employee count at Evoxx Technologies is 15.
What does Evoxx Technologies do?
Evoxx Technologies was established in 2006 as a spin-off from the Institute of Molecular Enzyme Technology at Heinrich-Heine University in Dusseldorf and Forschungszentrum Julich. Enzymes and biocatalytic processes are developed for the chemical and pharmaceutical sectors. A range of enzymes and customized bio-catalysts is provided for applications including textiles, adhesives, nutrition, and refinement processes. Laboratories adhere to S1 and S2 standards, with development scaled to commercial levels in Germany.
Who are the top competitors of Evoxx Technologies?
Evoxx Technologies's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Evoxx Technologies offer?
Evoxx Technologies offers Food Processing Enzymes, Biocatalysis Enzymes, and Human Nutrition Enzymes.
Who are Evoxx Technologies's investors?
Evoxx Technologies has 3 investors. Key investors include Advanced Enzyme Technologies, European Union, and High-Tech Gründerfonds.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.